Straits Times Index
3,287.75 -5.38 (-0.16%) S&P 500
5,005.00 -66.63 (-1.31%) Dow
37,820.48 -640.44 (-1.67%) Nasdaq
15,452.66 -260.09 (-1.66%) Bitcoin USD
63,410.47 -1,652.17 (-2.54%) CMC Crypto 200
1,371.70 -10.87 (-0.79%)
STAAR Surgical Company (STAA)
| Previous close | 47.82 |
| Open | 46.90 |
| Bid | 45.65 x 200 |
| Ask | 46.01 x 200 |
| Day's range | 45.78 - 47.05 |
| 52-week range | 26.66 - 73.13 |
| Volume | |
| Avg. volume | 722,798 |
| Market cap | 2.24B |
| Beta (5Y monthly) | 0.88 |
| PE ratio (TTM) | 106.58 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- Zacks
Strength Seen in Staar Surgical (STAA): Can Its 16.5% Jump Turn into More Strength?
Staar Surgical (STAA) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
- Benzinga
Eye Lens Maker STAAR Surgical Expects Q1 Sales To Beat Consensus
Thursday, STAAR Surgical Company (NASDAQ:STAA) reported preliminary net sales for the first quarter of 2024 of more than $77 million versus the consensus of $72.13 million, with U.S. ICL sales expected to be $5 million for the quarter. This represents the company’s highest quarterly ICL sales in the U.S. since the company obtained U.S. FDA approval for the EVO ICL in March 2022. “STAAR is off to a solid start in 2024 as illustrated by our preliminary first quarter results, including a record qua
- Simply Wall St.
Returns On Capital Are Showing Encouraging Signs At STAAR Surgical (NASDAQ:STAA)
If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Firstly, we'd...
